Skip to main content
. 2021 Sep 30;134(20):2430–2437. doi: 10.1097/CM9.0000000000001760

Figure 1.

Figure 1

Flow chart of the study. EGFR: Epidermal growth factor receptor; OS: Overall survival; PFS: Progression-free survival; RECIST: Response evaluation criteria in solid tumors; TKIs: Tyrosine kinase inhibitors.